AC
GILD icon

AXQ Capital’s Gilead Sciences GILD Stock Holding History

AXQ Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,757
Closed -$1.53M – 810
2025
Q3 		$1.53M Buy
+13,757
New +$1.56M 0.59% 13
2024
Q3 		– Sell
-21,659
Closed -$1.49M – 494
2024
Q2 		$1.49M Sell
21,659
-2,841
-12% -$190K 0.35% 97
2024
Q1 		$1.79M Buy
+24,500
New +$1.88M 0.43% 33
2023
Q1 		– Sell
-12,553
Closed -$1.08M – 538
2022
Q4 		$1.08M Buy
+12,553
New +$994K 0.75% 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AXQ Capital's GILD Position: Q4 2025 in Review

AXQ Capital sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 13,757 shares — an estimated $1.53M sold.

AXQ Capital first reported a position in GILD in Q4 2022 and held it in 4 quarters. The position peaked at $1.79M in Q1 2024. 2,215 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • AXQ Capital reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • AXQ Capital sold 13,757 Gilead Sciences shares in Q4 2025, an estimated $1.53M.
  • AXQ Capital first reported a position in Gilead Sciences in Q4 2022 and held it in 4 quarters.
  • AXQ Capital's Gilead Sciences position peaked at $1.79M in Q1 2024.
  • 2,215 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.